Results 221 to 230 of about 11,713 (255)

Ten-Year Follow-Up of Taliglucerase Alfa in Type 1 Gaucher Disease: Real-World Evidence from Albania. [PDF]

open access: yesJ Clin Med
Cullufi P   +12 more
europepmc   +1 more source

A guide to selecting high-performing antibodies for GCase (UniProt ID: P04062) for use in western blot, immunoprecipitation, and immunofluorescence. [PDF]

open access: yesF1000Res
Worrall D   +8 more
europepmc   +1 more source

Sustained release of a pharmacological chaperone that increases the activity of misfolded ß-Glucocerebrosidase

open access: gold, 2019
Hamidreza Enshaei   +7 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Glucocerebrosidase dysfunction in neurodegenerative disease

Essays in Biochemistry, 2021
Abstract Parkinson's disease (PD) and related neurodegenerative disorders, termed the synucleinopathies, are characterized pathologically by the accumulation of protein aggregates containing α-synuclein (aSyn), resulting in progressive neuronal loss.
Sarah M. Brooker, Dimitri Krainc
openaire   +2 more sources

Glucocerebrosidase (Gaucher disease)

Human Mutation, 1996
Gaucher disease is the most common glycolipid storage disorder, characterized by storage of the glycolipid, glucocerebroside in the liver, spleen, and marrow. The most prevalent form of Gaucher disease is designated type I (MIM 230800). Patients with type I disease may have hepatomegaly, splenomegaly, bone lesions, and less commonly, lung disease, but ...
E, Beutler, T, Gelbart
openaire   +2 more sources

Home - About - Disclaimer - Privacy